Care Fragmentation, Faulty Communication, and Documentation Lapses Derail a Treatment Plan

Abstract

This is the second Cancer Morbidity, Mortality, and Improvement Rounds, a series of articles intended to explore the unique safety risks experienced by oncology patients through the lens of quality improvement, systems and human factors engineering, and cognitive psychology. This case describes the care of a patient who was diagnosed with locally advanced lung cancer during the COVID-19 pandemic; it highlights how gaps in communication and care coordination caused the patient to receive care that did not reflect the consensus of his multidisciplinary team. The discussion highlights the importance of multidisciplinary care, particularly for patients with stage III non–small-cell lung cancer, discusses factors that led to communication gaps, and examines how we should assign accountability across dispersed health care systems.

Cancer Morbidity, Mortality, and Improvement Rounds is a series of articles intended to explore the unique safety risks experienced by oncology patients through the lens of quality improvement, systems and human factors engineering, and cognitive psychology. For purposes of clarity, each case focuses on a single theme, although, as is true for all medical incidents, there are almost always multiple, overlapping, contributing factors. The quality improvement paradigm used here, which focuses on root cause analyses and opportunities to improve care delivery systems, was previously outlined in this journal.

© 2022 by American Society of Clinical OncologyPRIOR PRESENTATION

Presented in part at a Morbidity, Mortality, and Improvement (MMI) conference at Dana-Farber Cancer Institute in Boston, MA on May 4th, 2022.

Conception and design: Thomas J. Roberts, Joseph O. Jacobson

Administrative support: Joseph O. Jacobson

Collection and assembly of data: All authors

Manuscript writing: All authors

Final approval of manuscript: All authors

Accountable for all aspects of the work: All authors

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Care Fragmentation, Faulty Communication, and Documentation Lapses Derail a Treatment Plan

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Thomas J. Roberts

Employment: Bicara Therapeutics, Biocon

Leadership: Biocon Biologics Ltd, Bicara Therapeutics

Stock and Other Ownership Interests: Biocon, Bicara Therapeutics

No other potential conflicts of interest were reported.

留言 (0)

沒有登入
gif